{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:49:46Z","timestamp":1773298186528,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"DOI":"10.2146\/ajhp140128","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T12:02:30Z","timestamp":1426680150000},"page":"536-541","source":"Crossref","is-referenced-by-count":7,"title":["Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism"],"prefix":"10.1093","volume":"72","author":[{"given":"Hayley","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Seltzer","sequence":"additional","affiliation":[{"name":"Pharmacotherapy Division, College of Pharmacy, University of Texas at Austin, San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Talbert","sequence":"additional","affiliation":[{"name":"Pharmacotherapy Division, College of Pharmacy, University of Texas at Austin, San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008311444400_b1-0720536","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041008311444400_b2-0720536","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041008311444400_b3-0720536","unstructured":"U.S. Census Bureau. Age and sex. www.census.gov\/population\/age\/ (accessed 2014 May 13)."},{"key":"key\n\t\t\t\t2019041008311444400_b4-0720536","first-page":"2536","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"95","author":"Wang","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041008311444400_b5-0720536","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol"},{"key":"key\n\t\t\t\t2019041008311444400_b6-0720536","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2006.06.034","article-title":"Testosterone and prostate cancer: an historical perspective on a modern myth","volume":"50","author":"Morgentaler","year":"2006","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b7-0720536","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-5347(05)64820-3","article-title":"Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941","volume":"168","author":"Huggins","year":"2002","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b8-0720536","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-5347(17)54531-0","article-title":"The response of metastatic adenocarcinoma of the prostate to exogenous testosterone","volume":"126","author":"Fowler","year":"1981","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b9-0720536","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/1097-0142(196711)20:11<1871::AID-CNCR2820201112>3.0.CO;2-D","article-title":"Response of men with advanced prostatic carcinoma to exogenous administration of testosterone","volume":"20","author":"Prout","year":"1967","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041008311444400_b10-0720536","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.ju.0000136269.10161.32","article-title":"Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men","volume":"172","author":"Kaufman","year":"2004","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b11-0720536","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.ju.0000143942.55896.64","article-title":"Testosterone replacement therapy after primary treatment for prostate cancer","volume":"173","author":"Agarwal","year":"2005","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b12-0720536","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.pcan.4500833","article-title":"Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients","volume":"9","author":"Ferreira","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key\n\t\t\t\t2019041008311444400_b13-0720536","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cncr.22438","article-title":"Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy","volume":"109","author":"Sarosdy","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041008311444400_b14-0720536","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2008.07882.x","article-title":"Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations","volume":"103","author":"Morales","year":"2009","journal-title":"BJU Int"},{"key":"key\n\t\t\t\t2019041008311444400_b15-0720536","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1743-6109.2009.01161.x","article-title":"Testosterone replacement therapy following radical prostatectomy","volume":"6","author":"Khera","year":"2009","journal-title":"J Sex Med"},{"key":"key\n\t\t\t\t2019041008311444400_b16-0720536","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1464-410X.2009.08980.x","article-title":"Testosterone replacement in prostate cancer survivors with hypogonadal symptoms","volume":"105","author":"Leibowitz","year":"2010","journal-title":"BJU Int"},{"key":"key\n\t\t\t\t2019041008311444400_b17-0720536","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ijir.2012.29","article-title":"Testosterone replacement therapy in the setting of prostate cancer treated with radiation","volume":"25","author":"Pastuszak","year":"2013","journal-title":"Int J Impot Res"},{"key":"key\n\t\t\t\t2019041008311444400_b18-0720536","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.juro.2013.02.002","article-title":"Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy","volume":"190","author":"Pastuszak","year":"2013","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b19-0720536","volume-title":"Pocket guide to diagnostic tests","author":"Nicoll","year":"2012","edition":"6th ed"},{"key":"key\n\t\t\t\t2019041008311444400_b20-0720536","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"key\n\t\t\t\t2019041008311444400_b21-0720536","unstructured":"American Urological Association. PSA testing for the pretreatment staging and posttreatment management of prostate cancer: 2013 revision of 2009 best practice statement. www.auanet.org\/common\/pdf\/education\/clinical-guidance\/Prostate-Specific-Antigen.pdf (accessed 2014 May 7)."},{"key":"key\n\t\t\t\t2019041008311444400_b22-0720536","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t2019041008311444400_b23-0720536","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","article-title":"Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041008311444400_b24-0720536","unstructured":"Roach M III DiBiase SJ . Brachytherapy for localized prostate cancer. www.uptodate.com\/contents\/brachytherapy-for-localized-prostate-cancer (accessed 2014 May 6)."},{"key":"key\n\t\t\t\t2019041008311444400_b25-0720536","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041008311444400_b26-0720536","unstructured":"Food and Drug Administration. Drugs@FDA: testosterone. www.fda.gov (accessed 2014 Nov 6)."},{"key":"key\n\t\t\t\t2019041008311444400_b27-0720536","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1200\/JCO.1999.17.11.3461","article-title":"Eligibility and response guidelines for phase II clinical trials in androgen independent prostate cancer: recommendations from the Prostate Specific Antigen Working Group","volume":"17","author":"Bubley","year":"1999","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041008311444400_b28-0720536","unstructured":"Cho S . Prostate cancer risk not elevated with testosterone replacement (May 7, 2013). www.renalandurologynews.com\/prostate-cancer-risk-not-elevated-with-testosterone-replacement\/article\/292346\/ (accessed 2014 May 10)."},{"key":"key\n\t\t\t\t2019041008311444400_b29-0720536","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041008311444400_b30-0720536","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1464-410X.2011.10193.x","article-title":"Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry","volume":"107","author":"Morales","year":"2011","journal-title":"BJU Int"},{"key":"key\n\t\t\t\t2019041008311444400_b31-0720536","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jsm.12429","article-title":"Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends","volume":"11","author":"Kaplan","year":"2014","journal-title":"J Sex Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/7\/536\/28319558\/ajhp0536.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T23:32:38Z","timestamp":1566430358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/7\/536\/5111484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140128","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,4,1]]},"published":{"date-parts":[[2015,4,1]]}}}